Showing 80 results
RBCV-based system enables targeted, stable thrombolytic drug delivery to clots, reducing bleeding risks in thrombosis treatment.
Broad neutralising monoclonal antibodies identified for SARS-CoV-2, enabling therapeutic strategies against coronaviruses.
Technology for advanced defect analysis in semiconductors, sensors, photonics, laser materials, and photovoltaics.
A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.
A simple, whole blood 2-gene expression signature that distinguishes bacterial infection from both viral infection and childhood inflammatory diseases.
Non-invasive blood test detects placental miRNAs at 13 weeks to predict small-for-gestational-age births, improving prenatal outcomes.
Blood-based microRNA markers predict ectopic or non-viable pregnancies early, improving diagnosis and treatment before ultrasound confirmation.
MyoLoop is a device that simulates the synchronised mechanical and electrical events that occur in the heart inside the body (in vivo), on an in vitro heart model known as myocardial slice.
MRI-based tool uses radiomics and AI to accurately detect and stratify Alzheimer’s and MCI, improving early diagnosis and trials.
A chimeric antigen receptor (CAR) construct specific for a T-cell receptor (TCR) beta-chain variable region subunit of a T cell.
A gene expression signature capable of simultaneous diagnosis of multiple diseases in children. The technology can detect 18 different infectious and inflammatory diseases in children that present with similar symptoms.
A novel growth medium for the culture of Lactobacillus iners to unprecedented high cell densities within 24 hours.